Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties.
Saved in:
| Title: | Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties. |
|---|---|
| Authors: | Jørstad ØK; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway. OEYJOE@ous-hf.no., Foss S; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway., Gjølberg TT; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway., Mester S; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway., Nyquist-Andersen M; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway., Sivertsen MS; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway., Fossum D; The Hospital Pharmacy Oslo, Ullevål, Norway., Gleditsch E; The Hospital Pharmacy Oslo, Ullevål, Norway., Moe MC; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Andersen JT; Department of Pharmacology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.; Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, Norway. |
| Source: | International journal of retina and vitreous [Int J Retina Vitreous] 2023 Nov 07; Vol. 9 (1), pp. 65. Date of Electronic Publication: 2023 Nov 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101677897 Publication Model: Electronic Cited Medium: Print ISSN: 2056-9920 (Print) Linking ISSN: 20569920 NLM ISO Abbreviation: Int J Retina Vitreous Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2056-9920 |
|---|---|
| DOI: | 10.1186/s40942-023-00507-3 |
